Career

Lillian Siu: Apply for the CRIS Cancer-Princess Margaret drug development fellowship

Photo from Lillian Siu/X

Apr 20, 2024, 20:07

Lillian Siu: Apply for the CRIS Cancer-Princess Margaret drug development fellowship

Quoting Lillian Siu’s post on X/Twitter:

“Apply for the CRIS Cancer-Princess Margaret drug development fellowship – great opportunity for those with interests in phase I trials and translational research.”

Source: Lillian Siu/X

Lillian Siu is a Professor of Medicine at the University of Toronto (Canada), senior medical oncologist, Director of the Phase I Program, Co-Director of the Bras and Family Drug Development Program and the Clinical Lead for the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre. She holds the BMO Chair in Precision Genomics (2016-2026). Dr. Siu served on the Board of Directors for the American Society of Clinical Oncology (ASCO), was a member of the Nomination Committee for the American Association for Cancer Research (AACR) (2014-2016), and currently serves on the AACR Board of Directors. She is a scientific editor for Cancer Discovery and is on the editorial board for JAMA Oncology.

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.